Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels

American Journal of Psychiatry

Volumn 156, Issue 9, 1999, Pages 1440-1443

  Volkow, Nora D ^a   Wang, Gene Jack ^b   Fowler, Joanna S ^b   Logan, Jean ^b   Gatley, Samuel J ^b   Gifford, Andrew ^b   Hitzemann, Robert ^b   Ding, Yu Shin ^b   Pappas, Naomi ^b  

^a Medical Department   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; DOPAMINE 2 RECEPTOR; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT; RACLOPRIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE PREDISPOSITION; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG DEPENDENCE; DRUG RECEPTOR BINDING; HUMAN; MALE; NEUROTRANSMISSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; CARBON RADIOISOTOPES; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; HUMANS; MALE; METHYLPHENIDATE; RACLOPRIDE; RECEPTORS, DOPAMINE D2; REINFORCEMENT (PSYCHOLOGY); REWARD; SALICYLAMIDES; SUBSTANCE-RELATED DISORDERS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032832347     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Blum K, Cull JC, Braverman ER, Comings DE: Reward deficiency syndrome. Am Sci 1996; 84:132-145
2. Goldman D, Urbanek M, Guenther D, Robin R, Long JC: A functionally deficient DRD2 variant [Ser311Cys] is not linked to alcoholism and substance abuse. Alcohol 1998; 16:47-52
3. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ: Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987; 237:1219-1223
4. Joyce PR, Donald RA, Nicholls MG, Lievesey JH, Abbott RM: Endocrine and behavioral responses to methylphenidate in normal subjects. Biol Psychiatry 1986; 21:1015-1023
5. Chait LD: Reinforcing and subjective effects of methylphenidate in humans. Behav Pharmacol 1994; 5:281-288
6. Sokoloff P, Schwartz JC: Novel dopamine receptors half a decade later. Trends Pharmacol Sci 1995; 16:270-275
7. 11C raclopride binding in the human brain. J Nucl Med 1993; 34: 609-613
8. Wang G-J, Volkow ND, Hitzemann RJ, Wong C, Angrist B, Burr G, Pascani K, Pappas N, Lu A, Cooper T, Lieberman JA: Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers. Eur Addict Res 1997; 3:49-54
9. 11C-methyl]cocaine PET studies in human subjects. J Cereb Blood Flow Metab 1990; 10:740-747
10. Endres CJ, Carson RE: Assessment of dynamic neurotransmitter changes with bolus or infusion delivery of neuroreceptorligands. J Cereb Blood Flow Metab 1998; 18:1196-1210
11. Glick SD, Raucci J, Wang S, Keller RW Jr, Carlson JN: Neurochemical predisposition to self-administer cocaine in rats: individual differences in dopamine and its metabolites. Brain Res 1994; 653:148-154
12. Chausmer AL, Ettenberg A: A role for D2, but not D1, dopamine receptors in the response-reinstating effects of food reinforcement. Pharmacol Biochem Behav 1997; 57:681-685
13. Davidson ES, Finch JF, Schenk S: Variability in subjective responses to cocaine: initial experiences of college students. Addict Behav 1993; 18:445-453
14. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R, Chen AD, Dewey SL, Pappas N: Decreased striatal dopaminergic responsivity in detoxified cocaine abusers. Nature 1997; 386:830-833
15. Phillips TJ, Brown KJ, Burkhart-Kasch S, Wenger CD, Kelly MA, Rubinstein M, Grandy DK, Low MJ: Alcohol preference and sensitivity are markedly reduced in mice lacking D2 receptors. Nat Neurosci 1998; 1:610-615
16. Maldonado R, Saiardi A, Valverde O, Samad TA, Roques BP, Borrelli E: Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 1997; 388:586-589
17. De Wit H, Wise RA: Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J Psychol 1977; 31:195-203
18. Spealman RD: Antagonism of behavioral effects of cocaine by selective dopamine receptor blockers. Psychopharmacology (Berl) 1990; 101:142-145
19. Berger SP, Hall S, Mickalian JD, Reid MS, Crawford CA, Delucchi K, Carr K, Hall S: Haloperidol antagonism of cue-elicited cocaine craving. Lancet 1996; 347:504-508
20. Sherer MA, Kumor KM, Jaffe JH: Effects of intravenous cocaine are partially attenuated by haloperidol. Psychiatry Res 1989; 27:117-125
21. Fischman MW, Foltin RW: Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addict 1991; 86:1563-1570